We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
-17.68%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$11.5B
AUM Growth
-$2.94B
Cap. Flow
-$38M
Cap. Flow %
-0.33%
Top 10 Hldgs %
32.02%
Holding
373
New
14
Increased
136
Reduced
156
Closed
44

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$161M
2
VZ icon
Verizon
VZ
+$114M
3
ABBV icon
AbbVie
ABBV
+$106M
4
PNC icon
PNC Financial Services
PNC
+$54.5M
5
AVGO icon
Broadcom
AVGO
+$50.1M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$121M
2
SPG icon
Simon Property Group
SPG
+$93.1M
3
XOM icon
ExxonMobil
XOM
+$71.5M
4
DRI icon
Darden Restaurants
DRI
+$60.2M
5
SYY icon
Sysco
SYY
+$58.6M

Sector Composition

Rank Sector Weight
1 Technology 19.5%
2 Healthcare 15.25%
3 Financials 13.5%
4 Consumer Staples 10.61%
5 Industrials 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNC icon
26
PNC Financial Services
PNC
$101B
$171M 1.49%
1,788,600
+406,045
+29% +$54.5M
CVX icon
27
Chevron
CVX
$366B
$169M 1.47%
2,329,590
+353,670
+18% +$34.9M
WEC icon
28
WEC Energy
WEC
$35.1B
$164M 1.43%
1,855,651
+37,897
+2% +$3.64M
MRK icon
29
Merck
MRK
$318B
$162M 1.42%
2,212,253
+2,051,093
+1,273% +$161M
ITW icon
30
Illinois Tool Works
ITW
$84.5B
$162M 1.41%
1,140,732
-14,348
-1% -$2.44M
AVGO icon
31
Broadcom
AVGO
$2.04T
$160M 1.4%
6,754,720
+1,776,800
+36% +$50.1M
LLY icon
32
Eli Lilly
LLY
$1.06T
$150M 1.3%
1,077,940
+71,522
+7% +$9.83M
ABBV icon
33
AbbVie
ABBV
$435B
$148M 1.29%
1,942,390
+1,244,985
+179% +$106M
CMCSA icon
34
Comcast
CMCSA
$90B
$139M 1.22%
4,057,033
+55,809
+1% +$2.35M
USB icon
35
US Bancorp
USB
$99.6B
$139M 1.21%
4,022,204
+62,197
+2% +$3M
KO icon
36
Coca-Cola
KO
$375B
$126M 1.1%
2,853,046
+260,572
+10% +$14.1M
AAPL icon
37
Apple
AAPL
$4.57T
$117M 1.02%
1,841,052
-308,248
-14% -$22.7M
VZ icon
38
Verizon
VZ
$196B
$111M 0.97%
2,071,621
+1,994,562
+2,588% +$114M
PFE icon
39
Pfizer
PFE
$153B
$96.7M 0.84%
3,123,763
-595,617
-16% -$20.3M
BR icon
40
Broadridge
BR
$19B
$91.5M 0.8%
964,704
+10,212
+1% +$1.17M
ACN icon
41
Accenture
ACN
$108B
$81.5M 0.71%
499,447
-1,486
-0.3% -$286K
O icon
42
Realty Income
O
$59.1B
$75M 0.65%
1,553,063
+34,205
+2% +$2.38M
PLD icon
43
Prologis
PLD
$133B
$74.4M 0.65%
926,010
+97,581
+12% +$8.52M
ETN icon
44
Eaton
ETN
$174B
$73.5M 0.64%
946,476
+380,341
+67% +$34.9M
MXIM
45
DELISTED
Maxim Integrated Products
MXIM
$65.5M 0.57%
1,346,960
+15,889
+1% +$911K
NOC icon
46
Northrop Grumman
NOC
$81.2B
$64M 0.56%
211,453
+21,512
+11% +$7.48M
CDW icon
47
CDW
CDW
$17B
$63.1M 0.55%
676,289
+743
+0.1% +$91K
EL icon
48
Estee Lauder
EL
$32B
$62.3M 0.54%
390,732
-27,924
-7% -$5.39M
PSX icon
49
Phillips 66
PSX
$81.4B
$60.7M 0.53%
1,131,801
+135,752
+14% +$11M
SYK icon
50
Stryker
SYK
$130B
$58.1M 0.51%
348,969
-594
-0.2% -$116K

Similar funds

Bahl & Gaynor's Q1 2020 Portfolio in Review

As of Q1 2020, Bahl & Gaynor held 373 positions worth $11.5B, down 20% from $14.4B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor's Q1 2020 filing shows 14 new, 136 increased, 156 reduced and 44 closed positions. Its largest new stake was M.D.C. Holdings, Inc.: 211,717 shares worth $4.55M. The largest sale was Microsoft, an estimated $121M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q1 2020 buy was M.D.C. Holdings, Inc.: 211,717 shares worth $4.55M.
  • Bahl & Gaynor added most to Merck in Q1 2020, an estimated $161M increase.
  • Bahl & Gaynor's biggest Q1 2020 reduction was Microsoft, cutting an estimated $121M.
  • Bahl & Gaynor fully exited Cinemark Holdings in Q1 2020, selling an estimated $6.07M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $11.5B portfolio in Q1 2020.
  • Bahl & Gaynor opened 14 new positions and closed 44 in Q1 2020.
  • Bahl & Gaynor's portfolio value fell 20% quarter-over-quarter to $11.5B.

Based on Bahl & Gaynor's 13F filing for Q1 2020, filed 15 May 2020.